Ledger.Open graph →
SEC Form D · filed November 7, 2023

Aligos Therapeutics, Inc

Offering
$92.2M
Sold
$92.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Andrew Pollard · Vancouver, British Columbia, CanadaExec · DirectorJames P. Scopa · South San Francisco, CADirectorAndre Penha · Sao Paulo/SP, GuernseyDirectorLesley A. Calhoun · South San Francisco, CAExecLeonid Beigelman · South San Francisco, CAExec · DirectorJames P. Scopa · South San Francisco, CADirectorJack A. Nielsen · South San Francisco, CADirectorDavid C. Schwab · Palo Alto, CAExecLawrence M. Blatt · South San Francisco, CAExec · DirectorCaoimhghin O'Donnell · Luxembourg, LuxembourgExec · DirectorBridget P. Martell · South San Francisco, CADirectorMatthew A. Mcclure · South San Francisco, CAExecRich Cannon · Alpharetta, GADirectorJulian P. Symons · South San Francisco, CAExecBradley N. Rothman · New York, NYDirectorPeter A. Hirth · South San Francisco, CADirectorBridget P. Martell · South San Francisco, CADirectorCarole P. Nuechterlein · South San Francisco, CADirectorJohn Seaberg · Vancouver, British Columbia, CanadaExec · DirectorCarole P. Nuechterlein · South San Francisco, CADirectorAnindya Bose · Alpharetta, GAExecLucinda A. Quan · South San Francisco, CAExecTony Wood · Vancouver, British Columbia, CanadaExecAlice H. Vilma · New York, NYDirectorHernan Kazah · Montevideo, X3DirectorWilliam Howald · Vancouver, British Columbia, CanadaExecLawrence M. Blatt · South San Francisco, CAExec · DirectorOrville Gordon · Alpharetta, GADirectorCarla A. Harris · New York, NYExecLesley A. Calhoun · South San Francisco, CAExecLarry Mohl · Alpharetta, GADirectorMatthew A. Mcclure · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗